OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Transcriptomics
(1)
Organisms
Homo sapiens
(1)
Repository
biostudies-arrayexpress
(1)
Publication Date
2007
(1)
Study type
Transcription profiling by array
(1)
Release Date
2016
(3)
2007
(1)
2024
(1)
2023
(1)
2021
(1)
2018
(1)
2017
(1)
2014
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2.
Not available
S-EPMC3618599
|
biostudies-literature
Cite
Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms.
Not available
S-EPMC4233160
|
biostudies-literature
Cite
Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies.
Not available
S-EPMC10807611
|
biostudies-literature
Cite
Phase 2 Study of Sorafenib, Valproic Acid, and Sildenafil in the Treatment of Recurrent High-Grade Glioma.
Not available
S-EPMC11071549
|
biostudies-literature
Cite
A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma.
Not available
S-EPMC5817887
|
biostudies-literature
Cite
Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas.
Not available
S-EPMC4798896
|
biostudies-literature
Cite
Transcription profiling of human lymph node (sinuses) and tonsil (no sinuses) to identify signature genes that are prime candidates for mediating adhesion of tumor cells to sinusoidal cells
Lymph node vs. tonsil
ORGANISM(S):
Homo sapiens
2007-09-12
|
E-GEOD-2665
|
biostudies-arrayexpress
Cite
A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma.
Not available
S-EPMC4775365
|
biostudies-literature
Cite
Family history of type 2 diabetes and characteristics of children with newly diagnosed type 1 diabetes.
Not available
S-EPMC7864815
|
biostudies-literature
Cite
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma.
Not available
S-EPMC11673799
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets